Baxter International Inc. is a global healthcare company that develops, manufactures, and markets medical products, including intravenous solutions, renal therapies, and biosurgery products.
This bond, identified by ISIN US071813BG33 and CUSIP 071813BG3, is a United States-issued obligation from Baxter International Inc., a prominent global healthcare company that develops, manufactures, and markets a broad range of products for critical medical conditions, including renal and hospital products, acute and chronic dialysis therapies, sterile IV solutions, and infusion systems; this specific debt instrument is currently priced at 100% of its face value in USD, offers a 4.5% annual coupon paid semi-annually, forms part of a $500,000,000 total issuance with a minimum purchase size of $2,000, matures on June 14, 2043, and holds investment-grade credit ratings of A- from Standard & Poor's and Baa1 from Moody's.
|